Latest Market News

APA Group has announced a modest 1.9% increase in its interim distribution to 27.5 cents per security for the half year ending December 2025, maintaining steady income growth for investors.

Lightning Minerals Ltd is set to launch a fully funded Phase 2 drilling campaign at its Mt Turner Gold Project in Queensland, following Phase 1 success that revealed a large mineralised system along a 12km strike of the Drummer Fault.

APA Group has announced an estimated ordinary dividend of AUD 0.275 per fully paid unit for the six months ending December 2025, alongside a Dividend Reinvestment Plan offering a 1.5% discount. The final dividend will be confirmed in February 2026.

Whitefield Industrials Limited has confirmed a fully franked ordinary dividend of AUD 0.105 per share for the half-year ending September 2025, alongside setting the Dividend Reinvestment Plan and Bonus Security Plan issue price at AUD 5.39.

Bioxyne Limited has secured a pioneering manufacturing and supply agreement to enter the emerging medicinal cannabis markets of Costa Rica and Panama, positioning itself as a first mover with promising revenue potential.

Brazilian Rare Earths Limited’s scoping study confirms the Amargosa Bauxite-Gallium Project as a large-scale, capital-efficient direct-ship bauxite operation with robust economic returns and strategic market positioning.

Jameson Resources has raised an extra A$450,000 through a discounted share placement, reinforcing investor confidence in its Crown Mountain coal project amid ongoing regulatory progress.

Norwest Minerals updates its West Arunta exploration strategy following a doubling of silver prices and a high-grade discovery at Dales Gossan, setting the stage for a major 2026 drilling campaign.

AMP has reached an agreement in principle to settle a long-running class action over commissions paid between 2014 and 2021, agreeing to pay $29 million without admitting liability.

Myer Holdings Limited reported steady FY25 financial results with $4.076 billion in sales and outlined ambitious growth strategies at its Annual General Meeting, alongside key director re-elections and executive incentives.

Neurizon Therapeutics has secured FDA clearance for its lead drug candidate NUZ-001 to enter the HEALEY ALS Platform Trial, marking a key regulatory milestone and setting the stage for patient enrollment in early 2026.

HomeCo Daily Needs REIT has reported a $219 million preliminary valuation gain alongside a strategic refinancing of $810 million in debt, reaffirming its FY26 distribution guidance amid strong portfolio fundamentals.